Skip to main content
Back to King's College London homepage

Dr Robson is a nephrologist with clinical and research interests in both glomerulonephritis and haemodialysis. He has a long record of laboratory research in experimental glomerulonephritis and is one of the lead consultants for a specialist clinic for patients with lupus, vasculitis and glomerular disease. He was also the Chief Investigator for the UK-wide PAVE trial, assessing drug-coated balloons in the treatment of arteriovenous fistulas.

Current research projects are clinical studies in patients on haemodialysis and in patients with lupus nephritis.

People

Clinical Trial Manager

Michael  Robson

Consultant nephrologist

Clinical Trial Manager

Clinical Research Fellow

Projects

PAVE2 logo
Paclitaxel or sirolimus coated balloons used for ArterioVEnous fistulas - 2 (PAVE-2 trial)

A UK-wide randomised controlled clinical trial to determine the efficacy of paclitaxel or sirolimus coated balloons in arteriovenous fistulas used for haemodialysis.

    Colchicine And Dialysis patients; a feasibility study (CAD)

    The primary objective of this study is to assess the feasibility of carrying out future trials of colchicine in dialysis patients.

      Publications

        People

        Clinical Trial Manager

        Michael  Robson

        Consultant nephrologist

        Clinical Trial Manager

        Clinical Research Fellow

        Projects

        PAVE2 logo
        Paclitaxel or sirolimus coated balloons used for ArterioVEnous fistulas - 2 (PAVE-2 trial)

        A UK-wide randomised controlled clinical trial to determine the efficacy of paclitaxel or sirolimus coated balloons in arteriovenous fistulas used for haemodialysis.

          Colchicine And Dialysis patients; a feasibility study (CAD)

          The primary objective of this study is to assess the feasibility of carrying out future trials of colchicine in dialysis patients.

            Publications

              Our Partners

              NIHR Logo

              National Institute for Health Research (NIHR)